ST Pharm Co.Ltd (237690) — Cash Flow Quality Index
Latest as of December 2025:
-0.68x
ST Pharm Co.Ltd (237690) has a Cash Flow Quality Index of -0.68x as of December 2025. Operating cash flow of ₩-21.16 Billion is below net income of ₩30.95 Billion, suggesting accrual-heavy earnings not yet converted to cash. Explore ST Pharm Co.Ltd cash debt coverage ratio to assess how comfortably operating cash covers total debt obligations.
Cash Flow Quality Index
-0.68x
Operating CF / Net Income
Operating Cash Flow
₩-21.16 Billion
KRW
Net Income
₩30.95 Billion
KRW
Data as of
Dec 2025
Most recent filing
ST Pharm Co.Ltd Cash Flow Quality Index (2015–2025)
Historical Cash Flow Quality Index for ST Pharm Co.Ltd across 8 annual periods. Values consistently above 1.0x indicate high-quality earnings. For the full cash flow conversion analysis, see 237690 cash generation efficiency.
Annual Cash Flow Quality Index for ST Pharm Co.Ltd (2015–2025)
Year-by-year earnings quality comparison for ST Pharm Co.Ltd.
| Year | Quality Index | Operating CF (KRW) | Net Income | YoY Change |
|---|---|---|---|---|
| 2025 | 0.25x | ₩13.99 Billion | ₩54.99 Billion | ▼ -94.4% |
| 2024 | 4.56x | ₩109.45 Billion | ₩24.02 Billion | ▲ +6049.4% |
| 2023 | 0.07x | ₩1.30 Billion | ₩17.52 Billion | ▼ -80.1% |
| 2022 | 0.37x | ₩7.03 Billion | ₩18.85 Billion | ▼ -75.8% |
| 2021 | 1.54x | ₩7.27 Billion | ₩4.71 Billion | ▲ +27.5% |
| 2017 | 1.21x | ₩54.44 Billion | ₩45.00 Billion | ▲ +46.4% |
| 2016 | 0.83x | ₩50.78 Billion | ₩61.43 Billion | ▼ -41.9% |
| 2015 | 1.42x | ₩35.82 Billion | ₩25.19 Billion | — |
Cash Flow Quality Index = Operating Cash Flow / Net Income. Ratios above 1.0x indicate cash-backed earnings.